Nika Pharmaceuticals Inc.
NIKA · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6 | $16 | $19 | $2 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $17 | $16 | $0 | $0 |
| Total Curr. Assets | $24 | $32 | $35 | $18 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $24 | $32 | $35 | $18 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $0 | $284 | $269 | $239 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $284 | $0 | -$269 | -$239 |
| Total Curr. Liab. | $284 | $284 | $269 | $239 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $284 | $284 | $269 | $239 |
| Equity | – | – | – | – |
| Pref Stock | $2 | $2 | $2 | $2 |
| Common Stock | $104 | $103 | $103 | $102 |
| Retained Earnings | -$8,967 | -$8,959 | -$8,941 | -$8,928 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $8,602 | $0 | $0 | $0 |
| Total Equity | -$261 | -$253 | -$234 | -$221 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $24 | $32 | $35 | $18 |
| Net Debt | -$6 | $269 | $250 | $237 |